It’s time for another edition of Reading Roundup featuring the top blog posts of June 2017. Start off your week by catching up on what the pharmaceutical industry was reading in June.
Extractables and Leachables: Not the Same – Part 2
As a follow-up to Extractables and Leachables: Not the Same – Part 1, this article details the QbD approach, and extractable and leachable evaluation methodology.
5 Megatrends in Biotechnological Factories of the Future
At the 2017 ISPE Europe Biotechnology Conference in Dublin, top pharmaceutical industry professionals and the National Institute for Bioresearch and Technology (NIBRT) will address the growth of biologics and its future impact. Find out more about the five major trends in biotechnology that will be addressed at the conference.
It’s Go Time! Where is Pharma at with Implementing Serialization?
At the 2017 ISPE Pharmaceutical Serialization Workshop in Philadelphia, Pennsylvania, representatives from Johnson & Johnson, Pfizer, Eli Lily, and other companies delivered presentations on where their companies stand on implementing serialization. Learn more about their findings and thoughts on implementing serialization.
Celebrating the Best of the Best in Pharma and Biotech Manufacturing Facilities
The 13th Annual Facility of the Year Awards (FOYA) banquet took place on Tuesday, 6 June in Arlington, Virginia. Find out more about this year’s celebration, the winners, and their award-winning projects.
2017 Quality Manufacturing Conference- FDA Regulatory Round Table
The last featured session of the 2017 ISPE/FDA/PQRI Quality Manufacturing Conference was the Regulatory round table on 7 June. Find out how a panel of FDA regulators responded when conference participants asked about topics such as quality metrics and the future of FDA regulation.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
